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Rnd proteins are atypical members of the Rho small
G protein family that inhibit the formation of acto-
myosin contractile fibers via activation of RhoGAPs
and inhibition of a Rho effector, the Ser/Thr kinase
Rock. These mechanisms might be used to fine-tune
Rho GTPase inhibition locally at sites where particu-
lar actin structures need to be made.
Within the past seven years several atypical members of
the Rho small G protein family have been discovered,
including RhoE/Rnd3, Rnd1, Rnd2, RhoD, Rif and
RhoH/TTF, to mention just the ones most closely related
to Rho. Rnd1, 2 and 3 represent a distinct sub-group
and, like other members of the Rho family, affect the
actin cytoskeleton, but with opposite effects, causing
disruption of actomyosin contractile fibers (‘stress
fibers’) and focal adhesions, leading to the ‘rounding’ of
fibroblasts (hence the name Rnd). 
The Rnd proteins have unusual biochemical proper-
ties compared with other Rho family GTPases. Canon-
ical members of this family are activated by the loading
of GTP, triggered by exchange factors, and are inacti-
vated by GTPase-activating proteins (GAPs), which
stimulate GTP hydrolysis and the return to the inactive
GDP-bound state. Most Rho family proteins are
geranyl-geranylated at their carboxyl terminus, which
promotes their membrane association in the GTP state.
In their resting GDP form, however, they are associated
with a guanine dissociation inhibitor (GDI) that masks
the geranyl-geranyl lipid moiety and keeps them in the
cytosol. The GDI has to be displaced by membrane-
associated GDI displacement factors, which so far are
still poorly characterized. In contrast, Rnd proteins are
farnesylated and predominantly associated with mem-
branes, suggesting that they are not associated with a
GDI. Because they have no GTPase activity and a low
affinity for GDP, and because there is usually about 10
times more GTP than GDP in cells, it seems likely that
Rnd1, Rnd2 and Rnd3/RhoE are always bound to GTP
and do not switch back to a GDP form [1]. Thus, Rnd
proteins would not be regulated by exchange factors or
GAPs, instead they can be considered as constitutively
active, and might be controlled exclusively by the
balance between transcription–translation and degra-
dation. In addition, they could be regulated by post-
translational modifications such as phosphorylation.
Another small G protein named Gem also affects
stress fiber formation. Gem belongs to a distinct sub-
group of the Ras family, which also comprises Kir and
Rad [2]. In contrast to Rnds, Gem proteins seem to
preferentially bind GDP. It is not yet clear whether they
physiologically bind GTP, but they apparently possess
very low, if any, intrinsic GTP hydrolysis activity.
Expression of Rnd proteins or Gem disrupts acto-
myosin contractile fibers. Several mechanisms could
possibly explain these antagonistic effects on Rho
function: these proteins could inhibit Rho activation by
blocking exchange factors or inhibiting GDI dissocia-
tion; they could possibly interact with some of the Rho
effectors, but with opposing effects; or they could stim-
ulate GAPs. Because exchange factors are the best
characterized regulators, the favorite model was that
Rnds would inhibit these factors; however our lab has
tested this hypothesis without finding such an inhibition
(our unpublished data). In fact, very recent findings by
several labs [3,4] have now shown that Rnds and Gem
use the other two proposed mechanisms to block Rho
function — inhibition of the Rho effector kinase Rock
and stimulation of RhoGAPs. 
Regulation of Rock
Rock is one of the most important Rho effectors and is
essential for the formation of contractile actomyosin
fibers. Rock phosphorylates and inhibits myosin light
chain (MLC) phosphatase, and may directly phospho-
rylate MLC itself, resulting in a significant increase in
MLC phosphorylation and incorporation of myosin to
cross-link actin filaments and form contractile fibers.
Rock has many other substrates, most of which also
control the cytoskeleton. The best known activator of
Rock is Rho, but Rock can also be activated by other
means, for instance the carboxyl terminus of ROCK I is
cleaved by caspase 3 during apoptosis, resulting in
dramatic changes in membrane–cytoskeleton interac-
tions, leading to membrane ‘blebbing’ [5,6]. Anne Ridley
and colleagues [3] have found that among Rho effec-
tors only Rock interacts with RhoE/Rnd3. However, like
many other kinases, Rock seems to be auto-inhibited in
a closed conformation, with the binding of Rho to a
central Rho-binding domain relieving this auto-inhibi-
tion. In such a model it is difficult to imagine how the
binding of a related protein, RhoE, at the same site, pre-
sumably in a very similar way, could have the opposite
effect (namely inhibiting Rock). 
An important breakthrough came with the discovery
that in fact RhoE/Rnd3 binds to Rock at a different
site, close to the kinase domain, inhibiting its activity
[3]. It is therefore much easier to understand how
RhoE/Rnd3 binding can inhibit Rock, whereas RhoA
binding at a different site activates it. In fact this group
has data suggesting that the activation of Rock by
RhoA and the generation of the ‘open’ conformation is
required before RhoE/Rnd3 can bind and subse-
quently inhibit, most likely in a second step [3]. There
are two highly related Rocks, ROCK I/ROKβ and
ROCK II/ROKα/Rho kinase, with similar structures and
mechanisms of activation, but probably different
modes of regulation. Ward and colleagues [7] have
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shown that Gem preferentially binds and inhibits
ROKβ whereas Rad preferentially binds ROKα. The
site of interaction is located in the central region of
Rock between the amino-terminal kinase domain and
the Rho-binding site at the carboxy-terminal end of
the central coiled-coil domain (Figure 1).
Those discoveries provide a new level of under-
standing of small G protein function, showing for the
first time that a single protein, Rock, can bind three dif-
ferent small G proteins on different sites. Rock is a
major Rho effector involved in bundling actin filaments
into stress fibers. However, Rho has several other
effectors, such as the Diaphanous-related formins (Dia
or DRF proteins), which, when activated, induce the
formation of many thin, non-bundled actin filaments. If
the only function of RhoE was to inhibit Rock, one
would expect to see other Rho effectors such as DRFs
still active, whereas RhoE/Rnd3 expression results in a
massive loss of F-actin, greater than that seen by inhi-
bition of Rock alone, suggesting that RhoE/Rnd3 has
additional effects. This finding indicates the complex-
ity of the regulation of Rho and its effectors in the mod-
ulation of the actin cytoskeleton.
Regulation of RhoGAPs
Another addition to the story has now been provided
by the group of Steen Hansen, in collaboration with
Jeff Settleman and Channing Der. Wennerberg et al. [4]
identified p190 RhoGAP as a binding partner for
Rnd3/RhoE by yeast two-hybrid analysis — not a com-
plete surprise because mouse RhoE had originally
been isolated in a two-hybrid screen using p190
RhoGAP as bait. Similar to the Rock story, the enlight-
enment came when the region of p190 RhoGAP that
interacts with RhoE was mapped and was found to lie
in a central domain of p190 RhoGAP with unknown
function and not in the RhoGAP domain, as first
assumed. Again, it was much easier to imagine how
RhoE/Rnd3 binding upstream of the RhoGAP domain
could recruit and activate this RhoGAP, and therefore
induce Rho inactivation. The authors went on to show
that Rnd3/RhoE expression in fibroblasts deficient in
either p190-A or p190-B induced a much weaker dis-
ruption of actomyosin contractile fibers than in cells
expressing normal levels of these two isoforms of
p190. This evidence strongly suggests that p190 is
indeed a major effector of Rnd3/RhoE induced stress-
fiber disruption [4]. 
Interestingly, other groups using different systems
have reached similar conclusions regarding the regu-
lation of RhoGAPs. De Gunzburg and colleagues [8]
found that Gem interacts and most likely activates a
RhoGAP named GMIP. Another GAP, MgcRacGAP, is
mostly expressed in male germ cells (Mgc), sperma-
tocytes and early spermatids, but Gacon and col-
leagues [9] could not detect any expression of Rho,
Rac or Cdc42 in these germ cells. In fact they found
that Rnd2, which is highly expressed in the testis,
interacts with MgcRacGAP and co-localizes with this
GAP in male germ cells. Rnd2 does not induce the
disruption of actomyosin fibers in Swiss 3T3 cells,
possibly because MgcRacGAP is expressed at much
lower levels than p190 which accounts for almost half
of the RhoGAP activity in fibroblasts [10]. MgcRac-
GAP also plays a major role in cytokinesis (as demon-
strated in Caenorhabditis elegans by the MgcRacGAP
homologue, CYK-4). In mammalian cells, the RhoGAP
activity of MgcRacGAP is controlled by the cytokine-
sis kinase Aurora [11], but it is not clear whether
MgcRacGAP’s role in cytokinesis also involves an
interaction with Rnds. This is clearly not the case in
flies and worms, which have no Rnd ortholog: aside
from mammals (man, mice, pig), an Rnd1 ortholog has
only been found in Xenopus.
This range of findings showing that Rnd3/RhoE,
Rnd2, and Gem affect actomyosin fibers by activating
different RhoGAPs (p190, MgcRacGAP and GMIP,
respectively) highlights the importance of GAPs in the
regulation of Rho activity. Little was known about the
mechanisms that control the ~60 different RhoGAPs
encoded in our genome. The best understood is p190
RhoGAP, which associates with p120RasGAP and is
regulated by tyrosine phosphorylation. Until recently,
however, the large central domain of p190 had no
known function, although, as described above the
binding of Rnd3/RhoE to this region has just been dis-
covered [4]. Local activation of p190 has already been
suggested in the case of insulin-like growth factor 1,
which directs tyrosine phosphorylation of p190-B
RhoGAP and its re-localization to lipid rafts where it
may encounter and inactivate Rho-GTP. In contrast, the
tyrosine phosphatase SHP-2 might dephosphorylate
p190-B RhoGAP and lead to its release from lipid rafts,
which would favor a sustained activation of Rho [12].
The recent discoveries provide us with new and
important insights into the regulation of GAP activity. It
is tempting to speculate that the recruitment of these
GAPs on membrane-associated Rnd3/RhoE or Gem
will induce a local inhibition of Rho. Then, how is the




(A) Schematic representation of p190 RhoGAP conserved
domains. A GTP-binding domain (GBD) is found in the amino
terminus and possibly a second one around position 700, with
four FF domains in between. These domains are followed by an
ArsB domain, and the RhoGAP domain is at the carboxyl termi-
nus. The major Src tyrosine phosphorylation site (Y) is in posi-
tion 1105 of p190-A. Rnd3/RhoE binds in the central domain
between positions 382 and 1007 of p190-B. (B) Schematic rep-
resentation of Rock, with the kinase domain in the amino termi-
nus which also contains the RhoE/Rnd3 binding site, the central
α-helical domain which harbors the Gem-binding site and the
Rho-binding site (RBD) followed by a PH domain and a cys-
teine-rich region (CRD) at the carboxyl terminus.
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Gem, which also binds ezrin (J. de Gunzburg, personal
communication), it might be the membrane recruitment
of ezrin that brings associated Gem and Gmip in the
vicinity of their substrate, whereas in the case of Rnds
an interaction with cadherins might be involved [1].
One can imagine that a cell segregates proteins at
its membrane to build a ‘mosaic’ with some places
where Rho activation will occur, and others where Rho
will be inhibited. Large ‘molecular machines’, or protein
complexes, are built at these sites. The complexes
responsible for activation contain at least a transmem-
brane protein, a GDI displacement factor (possibly
ERM proteins), an exchange factor and frequently
some pre-recruited effectors (such as Pak),  whereas
the inactivation complexes contain at least a trans-
membrane protein, a small G protein (such as Rnd or
Gem), and a GAP. The complexity of these molecular
machines emphasizes the precise regulation of small
G proteins, both temporally and spatially.
Rnd Proteins and Local Activation of Rho GTPases
A migrating cell extends long and thin membrane
protrusions known as filopodia whose functions are
to ‘explore’ the environment for migration clues such
as a chemo-attractant, or a neighboring cell. Their
protrusion is due to the polymerization of actin fila-
ments controlled by Cdc42 and the combined activ-
ity of several effectors including formins [13]. Some
of these filopodia mature into lamellipodia, formed
by large and highly dynamic structures of branched
filamentous actin in a Rac-dependent manner. The
first adhesion complexes, established at the rear of
these lamellipodia mature into stable focal adhesions
where the actomyosin fibers, controlled by Rho, are
anchored and develop force to drive the cell body
forward and move the nucleus. Finally these stable
adhesions have to detach at the trailing edge of the
cell. Thus, at least three different actin structures
controlled by Cdc42, Rac, and Rho, are required at
different places during cell migration and are mutu-
ally exclusive. 
Intuitively, one understands that at any given loca-
tion only one type of actin structure is made: for
example, local recruitment and activation of Rac pro-
motes lamellipodial formation (seen as membrane ruf-
fling), but it is important too that a stress fiber is not
formed at the same place, where it would induce
retraction. In filopodia or microspikes generated by
activated Cdc42, it seems that Rac and Rho activities
are locally inhibited, but as soon as Cdc42 is inacti-
vated, an increased ruffling is frequently seen. Ruffling
also occurs in response to growth factors such as EGF
or PDGF, due to the Rac exchange factor activity of
Sos which is recruited on receptors and activates Ras
and Rac [14]. p120 RasGAP is also recruited on acti-
vated receptors, together with p190 RhoGAP, which
could explain Rho inhibition in the context of Rac-
mediated ruffling. At present it is not known whether
another small G protein, such as Rnd3, also partici-
pates in p190 RhoGAP activation in this context. Thus,
it seems to be a common theme that in the region
where one Rho family member is activated the others
are usually inhibited. 
A cell moves by reptation (crawling), like a slug, and
the extension at the front has to be tightly coordinated
temporally, with contraction in the middle and retrac-
tion at the back, to make the movement effective.
Because the requirement for such coordination is quite
obvious, the underlying molecular mechanisms have
attracted little attention, and not much is known on the
spatial and temporal coordination mechanisms. Recent
work suggests that a major Rac effector, Pak, might
phosphorylate some Rho exchange factors and inhibit
them (A. Alberts and J. Frost, personal communication).
In addition to these few known examples, it seems
likely that localized inhibition might be due to the
expression and specific targeting of other family
members, such as Rnds or Gem, which could recruit
and activate specific GAPs.
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